Kyle Gano - 01 Nov 2024 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Chief Executive Officer, Director
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Issuer symbol
NBIX
Transactions as of
01 Nov 2024
Transactions value $
$0
Form type
4
Filing time
01 Nov 2024, 19:52:05 UTC
Previous filing
15 Feb 2024
Next filing
17 Jan 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NBIX Restricted Stock Unit Award $0 +2,455 $0.000000 2,455 01 Nov 2024 Common Stock 2,455 Direct F1, F2
transaction NBIX Stock Option Award $0 +13,344 $0.000000 13,344 01 Nov 2024 Common Stock 13,344 $122.21 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer Common Stock.
F2 The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of November 1, 2025, November 1, 2026, November 1, 2027, and November 1, 2028.
F3 Represents option of which 1/48th of the shares underlying the option becomes vested and exercisable on December 1, 2024 and an additional 1/48th of the shares underlying the option becomes vested and exercisable each month thereafter.